NEK2 as a prognostic marker and therapeutic target in adenocarcinoma of the lung

Abstract

Peer reviewed

Jun Zhang, Xin Zhan, Muhammad Furqan, Taher Abu Hejleh, Gerald H. Clamon, Shengxiang Ren and Fenghuang Zhan

Journal of clinical oncology, Vol.34(15_suppl), pp.e23282-e23282

05/20/2016

DOI: 10.1200/JCO.2016.34.15_suppl.e23282

View Online

Title: Subtitle: NEK2 as a prognostic marker and therapeutic target in adenocarcinoma of the lung
Creators: Jun Zhang - University of Iowa
Xin Zhan - University of Iowa
Muhammad Furqan - University of Iowa
Taher Abu Hejleh - University of Iowa
Gerald H. Clamon - University of Iowa
Shengxiang Ren - Shanghai Pulmonary Hospital
Fenghuang Zhan - University of Iowa
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.34(15_suppl), pp.e23282-e23282
DOI: 10.1200/JCO.2016.34.15_suppl.e23282
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2016
Academic Unit: Surgery; Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984362342102771

6 Record Views